Zojer, Niklas
Schreder, Martin
Ludwig, Heinz
Article History
Received: 3 May 2022
Accepted: 12 July 2022
First Online: 17 August 2022
Conflict of interest
: N. Zojer received honoraria (ad boards, lectures) from Janssen, BMS, Celgene, Amgen, Sanofi, Takeda. M. Schreder received honoraria (ad boards, lectures) from Janssen, BMS, Amgen, Sanofi, AbbVie, Pfizer. H. Ludwig received honoraria (ad boards and/or lectures) from Janssen, Sanofi, Takeda, GSK, BMS, Abbvie.